Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry-Based Method for Discrimination between Molecular Types of Cryptococcus neoformans and Cryptococcus gattii

Institute of Hygiene, Università Cattolica del Sacro Cuore, Rome, Italy.
Journal of clinical microbiology (Impact Factor: 4.23). 05/2012; 50(7):2472-6. DOI: 10.1128/JCM.00737-12
Source: PubMed

ABSTRACT We evaluated the usefulness of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) for Cryptococcus identification at the species and subspecies levels by using an in-house database of 25 reference cryptococcal spectra. Eighty-one out of the 82 Cryptococcus isolates (72 Cryptococcus neoformans and 10 Cryptococcus gattii) tested were correctly identified with respect to their molecular type designations. We showed that MALDI-TOF MS is a practicable alternative to conventional mycology or DNA-based methods.

  • Source
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Invasive infections have emerged over the past decades as important causes for morbidity and mortality. Favorable outcome is associated with early and appropriate antifungal treatment. Therefore, rapid and correct diagnosis is of utmost importance. The clinical mycology field has evolved over the past decade. Reference methods for susceptibility testing and associated clinical breakpoints for Candida and Aspergillus have been developed, and several commercial susceptibility tests have been marketed. New diagnostic tests have become available including ELISA and lateral flow devices for the detection of Aspergillus, Candida, and Cryptococcus antigens; β-d-glucan detection test; diagnostic PCRs; and matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) techniques for identification and perhaps in the future also for susceptibility screening (testing). Finally, molecular sequencing and genotyping methods have been described and increasingly used for outbreak and resistance detection. Some of these tests are straightforward to implement in the routine laboratory for clinical microbiology, whereas others require mycological expertise. Here, we present an overview of the newer diagnostic options, review options for improving sensitivity of classical diagnostic techniques, and also comment on which levels of mycological expertise are required for the different diagnostic tests. The goal of this review is to summarize current diagnostic options and discuss benefits and pitfalls on how these are best implemented in order to obtain state-of-the-art mycology service.
    Current Fungal Infection Reports 12/2014; 9(1). DOI:10.1007/s12281-014-0212-z
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cryptococcosis has emerged as an important public health problem in Africa, Asia and the Americas due to the increasing numbers of persons at risk of this infection and the adaptation of its aetiological agents to new environments. The proper management requires early recognition of Cryptococcus neoformans/C. gattii species complex infection, familiarity with the use and limitations of diagnostic tests and knowledge of the available treatment options. This review will address these issues with the goal of providing sufficient information to suspect, diagnose and treat patients with cryptococcosis based on Cuban data and review of the literature.
    Mycoses 12/2014; 57(12). DOI:10.1111/myc.12275 · 1.81 Impact Factor


Available from
May 17, 2014